Dicerna Pharmaceuticals, Inc. (DRNA) earnings
Quarterly and annual DRNA reports and results, each read against the price at its own news timestamp. Back to the DRNA overview →
No DRNA earnings events in the measured window.
Nothing matched in the current window — the DRNA overview has every event we measure for this name.
Get an email when DRNA moves on news →Keep exploring
More DRNA: analyst actions → · SEC filings → · DRNA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Integer Holdings Corporation (ITGR) | 1,059 | 0.00% | 49% |
| AMAG PHARMACEUTICALS (AMAG) | 1,055 | 0.00% | 49% |
| Arena Pharmaceuticals, Inc. (ARNA) | 1,052 | 0.00% | 47% |
| Global Blood Therapeutics, Inc. (GBT) | 1,048 | +0.13% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.